KV Brings Antitrust Allegations To Patent Suit
KV Pharmaceutical Co. on Tuesday filed an answer and counterclaims to Purdue Pharma LP's allegations of infringement of three patents for controlled-release oxycodone, claiming that the patents-in-suit are unenforceable because Purdue...To view the full article, register now.
Already a subscriber? Click here to view full article